Healthcare Industry News: coflex
News Release - June 25, 2007
SpineVision(R) Appoints Bertrand Lellouche as Chief Financial Officer
PARIS & SAN FRANCISCO--(HSMN NewsFeed)--SpineVision® announced today that it has appointed Bertrand Lellouche as Chief Financial Officer (CFO) of SpineVision SA, effective immediately.Mr. Lellouche has more than 15 years of experience in international financial management, including financial control and communication in an international environment. Most recently, he was Vice President and Chief Financial Officer (CFO) at Biomedical Diagnostics (BMD), an immunodiagnostics company headquartered in France. Prior to BMD, Mr. Lellouche was Vice President of Finance & Operations for GenOdyssee, a French-based drug discovery company. He has held several other senior financial positions since 1989 with other leading companies--including Technomed (medical), coflexip (oil services) and Vivendi-Environment--introducing each of these companies to the financial markets.
"Bertrand Lellouche has realized great success in communicating with the international financial community," said Julian Mackenzie, SpineVision's Chief Executive Officer (CEO). "I, personally, am looking forward to working closely with Bertrand to help us further establish SpineVision as a preeminent spine company not only in Europe but in the United States as well."
Mr. Lellouche holds a Master of Science degree in International Management from the MBA Institute Paris.
About SpineVision
SpineVision (www.spinevision.com) is exclusively focused on bringing innovative motion preservation and fusion devices to spine specialists around the world.
Source: SpineVision
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!